Global Cell and Advanced Therapies Supply Chain Management Supply, Demand and Key Producers, 2026-2032
The global Cell and Advanced Therapies Supply Chain Management market size is expected to reach $ 1762 million by 2032, rising at a market growth of 7.0% CAGR during the forecast period (2026-2032).
Cell and Advanced Therapies Supply Chain Management is a systematic approach to resource planning, traceability, and compliance management for cell therapy, gene therapy, and tissue engineering products, encompassing the entire process from collection, production, cold chain transportation to final clinical application. It covers therapies including CAR-T, TCR-T, stem cells, oncolytic viruses, and gene editing products. Core management stages include: donor material collection and transportation, plasmid/viral vector production, cell engineering and amplification, quality control and release, liquid nitrogen cryogenic storage, and patient reinfusion. This supply chain must strictly adhere to GMP/GTP standards and achieve end-to-end cold chain temperature monitoring (-196°C to -80°C) and on-chain traceability (batch, chain identity). Dedicated supply chain software is typically used to interface with ERP and clinical trial systems and is applied by pharmaceutical companies, CROs/CDMOs, and advanced therapeutic hospitals. Its goal is to ensure product quality stability, reduce transportation losses, and achieve full compliance throughout the process.
market is dominated by North America, led by European standards, and experiencing accelerated manufacturing and clinical applications in the Asia-Pacific region. North America (primarily the US) boasts mature commercial products such as CAR-T, driven by capital investment in vertical SaaS and hardware integration. Europe emphasizes end-to-end compliance and data privacy, with SAP Life Sciences Solutions and MAK-SYSTEM focusing on GMP-level manufacturing and transportation traceability. EMA regulations are driving the demand for closed-loop management of advanced therapies in hospitals. The Asia-Pacific region (China, Japan, and South Korea) is experiencing a surge in cell therapy clinical pipelines and policy support, leading companies like Genscript, WuXi AppTec, and NIPRO to rapidly localize their supply chains and accelerate their integration into international chains. Future trends include end-to-end blockchain traceability, automated liquid nitrogen storage and delivery via IoT, and integration with electronic medical data for cell therapy. Obstacles include the stability risks of multi-temperature cold chains (-80°C to -196°C), extremely narrow time windows from single-collection to reinfusion, and a lack of globally recognized digital interoperability standards.
This report studies the global Cell and Advanced Therapies Supply Chain Management demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell and Advanced Therapies Supply Chain Management, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Advanced Therapies Supply Chain Management that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell and Advanced Therapies Supply Chain Management total market, 2021-2032, (USD Million)
Global Cell and Advanced Therapies Supply Chain Management total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Cell and Advanced Therapies Supply Chain Management total market, key domestic companies, and share, (USD Million)
Global Cell and Advanced Therapies Supply Chain Management revenue by player, revenue and market share 2021-2026, (USD Million)
Global Cell and Advanced Therapies Supply Chain Management total market by Type, CAGR, 2021-2032, (USD Million)
Global Cell and Advanced Therapies Supply Chain Management total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Cell and Advanced Therapies Supply Chain Management market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, BioLife Solutions, Azenta, Modality Solutions, PCA, QuickSTAT, Be The Match BioTherapies, Brooks Life Sciences, Cryoport, Haemonetics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cell and Advanced Therapies Supply Chain Management market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cell and Advanced Therapies Supply Chain Management Market, By Region:
1. How big is the global Cell and Advanced Therapies Supply Chain Management market?
2. What is the demand of the global Cell and Advanced Therapies Supply Chain Management market?
3. What is the year over year growth of the global Cell and Advanced Therapies Supply Chain Management market?
4. What is the total value of the global Cell and Advanced Therapies Supply Chain Management market?
5. Who are the Major Players in the global Cell and Advanced Therapies Supply Chain Management market?
6. What are the growth factors driving the market demand?
Cell and Advanced Therapies Supply Chain Management is a systematic approach to resource planning, traceability, and compliance management for cell therapy, gene therapy, and tissue engineering products, encompassing the entire process from collection, production, cold chain transportation to final clinical application. It covers therapies including CAR-T, TCR-T, stem cells, oncolytic viruses, and gene editing products. Core management stages include: donor material collection and transportation, plasmid/viral vector production, cell engineering and amplification, quality control and release, liquid nitrogen cryogenic storage, and patient reinfusion. This supply chain must strictly adhere to GMP/GTP standards and achieve end-to-end cold chain temperature monitoring (-196°C to -80°C) and on-chain traceability (batch, chain identity). Dedicated supply chain software is typically used to interface with ERP and clinical trial systems and is applied by pharmaceutical companies, CROs/CDMOs, and advanced therapeutic hospitals. Its goal is to ensure product quality stability, reduce transportation losses, and achieve full compliance throughout the process.
market is dominated by North America, led by European standards, and experiencing accelerated manufacturing and clinical applications in the Asia-Pacific region. North America (primarily the US) boasts mature commercial products such as CAR-T, driven by capital investment in vertical SaaS and hardware integration. Europe emphasizes end-to-end compliance and data privacy, with SAP Life Sciences Solutions and MAK-SYSTEM focusing on GMP-level manufacturing and transportation traceability. EMA regulations are driving the demand for closed-loop management of advanced therapies in hospitals. The Asia-Pacific region (China, Japan, and South Korea) is experiencing a surge in cell therapy clinical pipelines and policy support, leading companies like Genscript, WuXi AppTec, and NIPRO to rapidly localize their supply chains and accelerate their integration into international chains. Future trends include end-to-end blockchain traceability, automated liquid nitrogen storage and delivery via IoT, and integration with electronic medical data for cell therapy. Obstacles include the stability risks of multi-temperature cold chains (-80°C to -196°C), extremely narrow time windows from single-collection to reinfusion, and a lack of globally recognized digital interoperability standards.
This report studies the global Cell and Advanced Therapies Supply Chain Management demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell and Advanced Therapies Supply Chain Management, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Advanced Therapies Supply Chain Management that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell and Advanced Therapies Supply Chain Management total market, 2021-2032, (USD Million)
Global Cell and Advanced Therapies Supply Chain Management total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Cell and Advanced Therapies Supply Chain Management total market, key domestic companies, and share, (USD Million)
Global Cell and Advanced Therapies Supply Chain Management revenue by player, revenue and market share 2021-2026, (USD Million)
Global Cell and Advanced Therapies Supply Chain Management total market by Type, CAGR, 2021-2032, (USD Million)
Global Cell and Advanced Therapies Supply Chain Management total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Cell and Advanced Therapies Supply Chain Management market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, BioLife Solutions, Azenta, Modality Solutions, PCA, QuickSTAT, Be The Match BioTherapies, Brooks Life Sciences, Cryoport, Haemonetics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cell and Advanced Therapies Supply Chain Management market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cell and Advanced Therapies Supply Chain Management Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cloud
- On-premises
- Collection
- Production and Manufacturing
- Cold Chain Transportation
- Storage
- Clinical Use
- Others
- Ambient Temperature (15-25°C)
- Refrigerated (2-8°C)
- Frozen (-20°C)
- Deep-frozen (-80°C)
- Cryogenic Temperature (-196°C)
- Biobank
- Cell Therapy Lab
- Hospital
- Research Institute
- Commercial Organization
- Thermo Fisher Scientific
- BioLife Solutions
- Azenta
- Modality Solutions
- PCA
- QuickSTAT
- Be The Match BioTherapies
- Brooks Life Sciences
- Cryoport
- Haemonetics
- Hypertrust Patient Data Care
- Lykan Bioscience
- MAK-SYSTEM
- MasterControl
- SAP
- SAVSU Technologies
- sedApta Group
- Stafa Cellular Therapy
- Title21 Health Solutions
- TraceLink
- TrakCel
- Vineti
- Lonza
- Sartorius
- BioOutsource
- GenScript
- WuXi AppTec
- Pharmaron
- JOINN
- NIPRO
- Kawasaki Heavy Industries
- JCR Pharmaceuticals
- Fujifilm Cellular Dynamics
1. How big is the global Cell and Advanced Therapies Supply Chain Management market?
2. What is the demand of the global Cell and Advanced Therapies Supply Chain Management market?
3. What is the year over year growth of the global Cell and Advanced Therapies Supply Chain Management market?
4. What is the total value of the global Cell and Advanced Therapies Supply Chain Management market?
5. Who are the Major Players in the global Cell and Advanced Therapies Supply Chain Management market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cell and Advanced Therapies Supply Chain Management Introduction
1.2 World Cell and Advanced Therapies Supply Chain Management Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Cell and Advanced Therapies Supply Chain Management Total Market by Region (by Headquarter Location)
1.3.1 World Cell and Advanced Therapies Supply Chain Management Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.3.3 China Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.3.4 Europe Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.3.5 Japan Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.3.6 South Korea Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.3.7 ASEAN Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.3.8 India Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell and Advanced Therapies Supply Chain Management Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.2 World Cell and Advanced Therapies Supply Chain Management Consumption Value by Region
2.2.1 World Cell and Advanced Therapies Supply Chain Management Consumption Value by Region (2021-2026)
2.2.2 World Cell and Advanced Therapies Supply Chain Management Consumption Value Forecast by Region (2027-2032)
2.3 United States Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.4 China Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.5 Europe Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.6 Japan Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.7 South Korea Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.8 ASEAN Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.9 India Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
3 WORLD CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell and Advanced Therapies Supply Chain Management Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell and Advanced Therapies Supply Chain Management Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell and Advanced Therapies Supply Chain Management in 2025
3.2.3 Global Concentration Ratios (CR8) for Cell and Advanced Therapies Supply Chain Management in 2025
3.3 Cell and Advanced Therapies Supply Chain Management Company Evaluation Quadrant
3.4 Cell and Advanced Therapies Supply Chain Management Market: Overall Company Footprint Analysis
3.4.1 Cell and Advanced Therapies Supply Chain Management Market: Region Footprint
3.4.2 Cell and Advanced Therapies Supply Chain Management Market: Company Product Type Footprint
3.4.3 Cell and Advanced Therapies Supply Chain Management Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell and Advanced Therapies Supply Chain Management Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell and Advanced Therapies Supply Chain Management Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Cell and Advanced Therapies Supply Chain Management Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Cell and Advanced Therapies Supply Chain Management Consumption Value Comparison
4.2.1 United States VS China: Cell and Advanced Therapies Supply Chain Management Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cell and Advanced Therapies Supply Chain Management Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Cell and Advanced Therapies Supply Chain Management Companies and Market Share, 2021-2026
4.3.1 United States Based Cell and Advanced Therapies Supply Chain Management Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell and Advanced Therapies Supply Chain Management Revenue, (2021-2026)
4.4 China Based Companies Cell and Advanced Therapies Supply Chain Management Revenue and Market Share, 2021-2026
4.4.1 China Based Cell and Advanced Therapies Supply Chain Management Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell and Advanced Therapies Supply Chain Management Revenue, (2021-2026)
4.5 Rest of World Based Cell and Advanced Therapies Supply Chain Management Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Cell and Advanced Therapies Supply Chain Management Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Cell and Advanced Therapies Supply Chain Management Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell and Advanced Therapies Supply Chain Management Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Cloud
5.2.2 On-premises
5.3 Market Segment by Type
5.3.1 World Cell and Advanced Therapies Supply Chain Management Market Size by Type (2021-2026)
5.3.2 World Cell and Advanced Therapies Supply Chain Management Market Size by Type (2027-2032)
5.3.3 World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SUPPLY CHAIN
6.1 World Cell and Advanced Therapies Supply Chain Management Market Size Overview by Supply Chain: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Supply Chain
6.2.1 Collection
6.2.2 Production and Manufacturing
6.2.3 Cold Chain Transportation
6.2.4 Storage
6.2.5 Clinical Use
6.2.6 Others
6.3 Market Segment by Supply Chain
6.3.1 World Cell and Advanced Therapies Supply Chain Management Market Size by Supply Chain (2021-2026)
6.3.2 World Cell and Advanced Therapies Supply Chain Management Market Size by Supply Chain (2027-2032)
6.3.3 World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Supply Chain (2027-2032)
7 MARKET ANALYSIS BY TEMPERATURE
7.1 World Cell and Advanced Therapies Supply Chain Management Market Size Overview by Temperature: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Temperature
7.2.1 Ambient Temperature (15-25°C)
7.2.2 Refrigerated (2-8°C)
7.2.3 Frozen (-20°C)
7.2.4 Deep-frozen (-80°C)
7.2.5 Cryogenic Temperature (-196°C)
7.3 Market Segment by Temperature
7.3.1 World Cell and Advanced Therapies Supply Chain Management Market Size by Temperature (2021-2026)
7.3.2 World Cell and Advanced Therapies Supply Chain Management Market Size by Temperature (2027-2032)
7.3.3 World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Temperature (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cell and Advanced Therapies Supply Chain Management Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Biobank
8.2.2 Cell Therapy Lab
8.2.3 Hospital
8.2.4 Research Institute
8.2.5 Commercial Organization
8.3 Market Segment by Application
8.3.1 World Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026)
8.3.2 World Cell and Advanced Therapies Supply Chain Management Market Size by Application (2027-2032)
8.3.3 World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific Cell and Advanced Therapies Supply Chain Management Product and Services
9.1.4 Thermo Fisher Scientific Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 BioLife Solutions
9.2.1 BioLife Solutions Details
9.2.2 BioLife Solutions Major Business
9.2.3 BioLife Solutions Cell and Advanced Therapies Supply Chain Management Product and Services
9.2.4 BioLife Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 BioLife Solutions Recent Developments/Updates
9.2.6 BioLife Solutions Competitive Strengths & Weaknesses
9.3 Azenta
9.3.1 Azenta Details
9.3.2 Azenta Major Business
9.3.3 Azenta Cell and Advanced Therapies Supply Chain Management Product and Services
9.3.4 Azenta Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Azenta Recent Developments/Updates
9.3.6 Azenta Competitive Strengths & Weaknesses
9.4 Modality Solutions
9.4.1 Modality Solutions Details
9.4.2 Modality Solutions Major Business
9.4.3 Modality Solutions Cell and Advanced Therapies Supply Chain Management Product and Services
9.4.4 Modality Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Modality Solutions Recent Developments/Updates
9.4.6 Modality Solutions Competitive Strengths & Weaknesses
9.5 PCA
9.5.1 PCA Details
9.5.2 PCA Major Business
9.5.3 PCA Cell and Advanced Therapies Supply Chain Management Product and Services
9.5.4 PCA Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 PCA Recent Developments/Updates
9.5.6 PCA Competitive Strengths & Weaknesses
9.6 QuickSTAT
9.6.1 QuickSTAT Details
9.6.2 QuickSTAT Major Business
9.6.3 QuickSTAT Cell and Advanced Therapies Supply Chain Management Product and Services
9.6.4 QuickSTAT Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 QuickSTAT Recent Developments/Updates
9.6.6 QuickSTAT Competitive Strengths & Weaknesses
9.7 Be The Match BioTherapies
9.7.1 Be The Match BioTherapies Details
9.7.2 Be The Match BioTherapies Major Business
9.7.3 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product and Services
9.7.4 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Be The Match BioTherapies Recent Developments/Updates
9.7.6 Be The Match BioTherapies Competitive Strengths & Weaknesses
9.8 Brooks Life Sciences
9.8.1 Brooks Life Sciences Details
9.8.2 Brooks Life Sciences Major Business
9.8.3 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product and Services
9.8.4 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Brooks Life Sciences Recent Developments/Updates
9.8.6 Brooks Life Sciences Competitive Strengths & Weaknesses
9.9 Cryoport
9.9.1 Cryoport Details
9.9.2 Cryoport Major Business
9.9.3 Cryoport Cell and Advanced Therapies Supply Chain Management Product and Services
9.9.4 Cryoport Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Cryoport Recent Developments/Updates
9.9.6 Cryoport Competitive Strengths & Weaknesses
9.10 Haemonetics
9.10.1 Haemonetics Details
9.10.2 Haemonetics Major Business
9.10.3 Haemonetics Cell and Advanced Therapies Supply Chain Management Product and Services
9.10.4 Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Haemonetics Recent Developments/Updates
9.10.6 Haemonetics Competitive Strengths & Weaknesses
9.11 Hypertrust Patient Data Care
9.11.1 Hypertrust Patient Data Care Details
9.11.2 Hypertrust Patient Data Care Major Business
9.11.3 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product and Services
9.11.4 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Hypertrust Patient Data Care Recent Developments/Updates
9.11.6 Hypertrust Patient Data Care Competitive Strengths & Weaknesses
9.12 Lykan Bioscience
9.12.1 Lykan Bioscience Details
9.12.2 Lykan Bioscience Major Business
9.12.3 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product and Services
9.12.4 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Lykan Bioscience Recent Developments/Updates
9.12.6 Lykan Bioscience Competitive Strengths & Weaknesses
9.13 MAK-SYSTEM
9.13.1 MAK-SYSTEM Details
9.13.2 MAK-SYSTEM Major Business
9.13.3 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product and Services
9.13.4 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 MAK-SYSTEM Recent Developments/Updates
9.13.6 MAK-SYSTEM Competitive Strengths & Weaknesses
9.14 MasterControl
9.14.1 MasterControl Details
9.14.2 MasterControl Major Business
9.14.3 MasterControl Cell and Advanced Therapies Supply Chain Management Product and Services
9.14.4 MasterControl Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 MasterControl Recent Developments/Updates
9.14.6 MasterControl Competitive Strengths & Weaknesses
9.15 SAP
9.15.1 SAP Details
9.15.2 SAP Major Business
9.15.3 SAP Cell and Advanced Therapies Supply Chain Management Product and Services
9.15.4 SAP Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 SAP Recent Developments/Updates
9.15.6 SAP Competitive Strengths & Weaknesses
9.16 SAVSU Technologies
9.16.1 SAVSU Technologies Details
9.16.2 SAVSU Technologies Major Business
9.16.3 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product and Services
9.16.4 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 SAVSU Technologies Recent Developments/Updates
9.16.6 SAVSU Technologies Competitive Strengths & Weaknesses
9.17 sedApta Group
9.17.1 sedApta Group Details
9.17.2 sedApta Group Major Business
9.17.3 sedApta Group Cell and Advanced Therapies Supply Chain Management Product and Services
9.17.4 sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 sedApta Group Recent Developments/Updates
9.17.6 sedApta Group Competitive Strengths & Weaknesses
9.18 Stafa Cellular Therapy
9.18.1 Stafa Cellular Therapy Details
9.18.2 Stafa Cellular Therapy Major Business
9.18.3 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product and Services
9.18.4 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Stafa Cellular Therapy Recent Developments/Updates
9.18.6 Stafa Cellular Therapy Competitive Strengths & Weaknesses
9.19 Title21 Health Solutions
9.19.1 Title21 Health Solutions Details
9.19.2 Title21 Health Solutions Major Business
9.19.3 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product and Services
9.19.4 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Title21 Health Solutions Recent Developments/Updates
9.19.6 Title21 Health Solutions Competitive Strengths & Weaknesses
9.20 TraceLink
9.20.1 TraceLink Details
9.20.2 TraceLink Major Business
9.20.3 TraceLink Cell and Advanced Therapies Supply Chain Management Product and Services
9.20.4 TraceLink Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 TraceLink Recent Developments/Updates
9.20.6 TraceLink Competitive Strengths & Weaknesses
9.21 TrakCel
9.21.1 TrakCel Details
9.21.2 TrakCel Major Business
9.21.3 TrakCel Cell and Advanced Therapies Supply Chain Management Product and Services
9.21.4 TrakCel Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 TrakCel Recent Developments/Updates
9.21.6 TrakCel Competitive Strengths & Weaknesses
9.22 Vineti
9.22.1 Vineti Details
9.22.2 Vineti Major Business
9.22.3 Vineti Cell and Advanced Therapies Supply Chain Management Product and Services
9.22.4 Vineti Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Vineti Recent Developments/Updates
9.22.6 Vineti Competitive Strengths & Weaknesses
9.23 Lonza
9.23.1 Lonza Details
9.23.2 Lonza Major Business
9.23.3 Lonza Cell and Advanced Therapies Supply Chain Management Product and Services
9.23.4 Lonza Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Lonza Recent Developments/Updates
9.23.6 Lonza Competitive Strengths & Weaknesses
9.24 Sartorius
9.24.1 Sartorius Details
9.24.2 Sartorius Major Business
9.24.3 Sartorius Cell and Advanced Therapies Supply Chain Management Product and Services
9.24.4 Sartorius Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Sartorius Recent Developments/Updates
9.24.6 Sartorius Competitive Strengths & Weaknesses
9.25 BioOutsource
9.25.1 BioOutsource Details
9.25.2 BioOutsource Major Business
9.25.3 BioOutsource Cell and Advanced Therapies Supply Chain Management Product and Services
9.25.4 BioOutsource Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 BioOutsource Recent Developments/Updates
9.25.6 BioOutsource Competitive Strengths & Weaknesses
9.26 GenScript
9.26.1 GenScript Details
9.26.2 GenScript Major Business
9.26.3 GenScript Cell and Advanced Therapies Supply Chain Management Product and Services
9.26.4 GenScript Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 GenScript Recent Developments/Updates
9.26.6 GenScript Competitive Strengths & Weaknesses
9.27 WuXi AppTec
9.27.1 WuXi AppTec Details
9.27.2 WuXi AppTec Major Business
9.27.3 WuXi AppTec Cell and Advanced Therapies Supply Chain Management Product and Services
9.27.4 WuXi AppTec Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 WuXi AppTec Recent Developments/Updates
9.27.6 WuXi AppTec Competitive Strengths & Weaknesses
9.28 Pharmaron
9.28.1 Pharmaron Details
9.28.2 Pharmaron Major Business
9.28.3 Pharmaron Cell and Advanced Therapies Supply Chain Management Product and Services
9.28.4 Pharmaron Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Pharmaron Recent Developments/Updates
9.28.6 Pharmaron Competitive Strengths & Weaknesses
9.29 JOINN
9.29.1 JOINN Details
9.29.2 JOINN Major Business
9.29.3 JOINN Cell and Advanced Therapies Supply Chain Management Product and Services
9.29.4 JOINN Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 JOINN Recent Developments/Updates
9.29.6 JOINN Competitive Strengths & Weaknesses
9.30 NIPRO
9.30.1 NIPRO Details
9.30.2 NIPRO Major Business
9.30.3 NIPRO Cell and Advanced Therapies Supply Chain Management Product and Services
9.30.4 NIPRO Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 NIPRO Recent Developments/Updates
9.30.6 NIPRO Competitive Strengths & Weaknesses
9.31 Kawasaki Heavy Industries
9.31.1 Kawasaki Heavy Industries Details
9.31.2 Kawasaki Heavy Industries Major Business
9.31.3 Kawasaki Heavy Industries Cell and Advanced Therapies Supply Chain Management Product and Services
9.31.4 Kawasaki Heavy Industries Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Kawasaki Heavy Industries Recent Developments/Updates
9.31.6 Kawasaki Heavy Industries Competitive Strengths & Weaknesses
9.32 JCR Pharmaceuticals
9.32.1 JCR Pharmaceuticals Details
9.32.2 JCR Pharmaceuticals Major Business
9.32.3 JCR Pharmaceuticals Cell and Advanced Therapies Supply Chain Management Product and Services
9.32.4 JCR Pharmaceuticals Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 JCR Pharmaceuticals Recent Developments/Updates
9.32.6 JCR Pharmaceuticals Competitive Strengths & Weaknesses
9.33 Fujifilm Cellular Dynamics
9.33.1 Fujifilm Cellular Dynamics Details
9.33.2 Fujifilm Cellular Dynamics Major Business
9.33.3 Fujifilm Cellular Dynamics Cell and Advanced Therapies Supply Chain Management Product and Services
9.33.4 Fujifilm Cellular Dynamics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 Fujifilm Cellular Dynamics Recent Developments/Updates
9.33.6 Fujifilm Cellular Dynamics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cell and Advanced Therapies Supply Chain Management Industry Chain
10.2 Cell and Advanced Therapies Supply Chain Management Upstream Analysis
10.3 Cell and Advanced Therapies Supply Chain Management Midstream Analysis
10.4 Cell and Advanced Therapies Supply Chain Management Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Cell and Advanced Therapies Supply Chain Management Introduction
1.2 World Cell and Advanced Therapies Supply Chain Management Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Cell and Advanced Therapies Supply Chain Management Total Market by Region (by Headquarter Location)
1.3.1 World Cell and Advanced Therapies Supply Chain Management Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.3.3 China Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.3.4 Europe Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.3.5 Japan Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.3.6 South Korea Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.3.7 ASEAN Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.3.8 India Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell and Advanced Therapies Supply Chain Management Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.2 World Cell and Advanced Therapies Supply Chain Management Consumption Value by Region
2.2.1 World Cell and Advanced Therapies Supply Chain Management Consumption Value by Region (2021-2026)
2.2.2 World Cell and Advanced Therapies Supply Chain Management Consumption Value Forecast by Region (2027-2032)
2.3 United States Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.4 China Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.5 Europe Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.6 Japan Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.7 South Korea Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.8 ASEAN Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
2.9 India Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032)
3 WORLD CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell and Advanced Therapies Supply Chain Management Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell and Advanced Therapies Supply Chain Management Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell and Advanced Therapies Supply Chain Management in 2025
3.2.3 Global Concentration Ratios (CR8) for Cell and Advanced Therapies Supply Chain Management in 2025
3.3 Cell and Advanced Therapies Supply Chain Management Company Evaluation Quadrant
3.4 Cell and Advanced Therapies Supply Chain Management Market: Overall Company Footprint Analysis
3.4.1 Cell and Advanced Therapies Supply Chain Management Market: Region Footprint
3.4.2 Cell and Advanced Therapies Supply Chain Management Market: Company Product Type Footprint
3.4.3 Cell and Advanced Therapies Supply Chain Management Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell and Advanced Therapies Supply Chain Management Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell and Advanced Therapies Supply Chain Management Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Cell and Advanced Therapies Supply Chain Management Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Cell and Advanced Therapies Supply Chain Management Consumption Value Comparison
4.2.1 United States VS China: Cell and Advanced Therapies Supply Chain Management Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cell and Advanced Therapies Supply Chain Management Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Cell and Advanced Therapies Supply Chain Management Companies and Market Share, 2021-2026
4.3.1 United States Based Cell and Advanced Therapies Supply Chain Management Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell and Advanced Therapies Supply Chain Management Revenue, (2021-2026)
4.4 China Based Companies Cell and Advanced Therapies Supply Chain Management Revenue and Market Share, 2021-2026
4.4.1 China Based Cell and Advanced Therapies Supply Chain Management Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell and Advanced Therapies Supply Chain Management Revenue, (2021-2026)
4.5 Rest of World Based Cell and Advanced Therapies Supply Chain Management Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Cell and Advanced Therapies Supply Chain Management Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Cell and Advanced Therapies Supply Chain Management Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell and Advanced Therapies Supply Chain Management Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Cloud
5.2.2 On-premises
5.3 Market Segment by Type
5.3.1 World Cell and Advanced Therapies Supply Chain Management Market Size by Type (2021-2026)
5.3.2 World Cell and Advanced Therapies Supply Chain Management Market Size by Type (2027-2032)
5.3.3 World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SUPPLY CHAIN
6.1 World Cell and Advanced Therapies Supply Chain Management Market Size Overview by Supply Chain: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Supply Chain
6.2.1 Collection
6.2.2 Production and Manufacturing
6.2.3 Cold Chain Transportation
6.2.4 Storage
6.2.5 Clinical Use
6.2.6 Others
6.3 Market Segment by Supply Chain
6.3.1 World Cell and Advanced Therapies Supply Chain Management Market Size by Supply Chain (2021-2026)
6.3.2 World Cell and Advanced Therapies Supply Chain Management Market Size by Supply Chain (2027-2032)
6.3.3 World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Supply Chain (2027-2032)
7 MARKET ANALYSIS BY TEMPERATURE
7.1 World Cell and Advanced Therapies Supply Chain Management Market Size Overview by Temperature: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Temperature
7.2.1 Ambient Temperature (15-25°C)
7.2.2 Refrigerated (2-8°C)
7.2.3 Frozen (-20°C)
7.2.4 Deep-frozen (-80°C)
7.2.5 Cryogenic Temperature (-196°C)
7.3 Market Segment by Temperature
7.3.1 World Cell and Advanced Therapies Supply Chain Management Market Size by Temperature (2021-2026)
7.3.2 World Cell and Advanced Therapies Supply Chain Management Market Size by Temperature (2027-2032)
7.3.3 World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Temperature (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cell and Advanced Therapies Supply Chain Management Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Biobank
8.2.2 Cell Therapy Lab
8.2.3 Hospital
8.2.4 Research Institute
8.2.5 Commercial Organization
8.3 Market Segment by Application
8.3.1 World Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026)
8.3.2 World Cell and Advanced Therapies Supply Chain Management Market Size by Application (2027-2032)
8.3.3 World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific Cell and Advanced Therapies Supply Chain Management Product and Services
9.1.4 Thermo Fisher Scientific Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 BioLife Solutions
9.2.1 BioLife Solutions Details
9.2.2 BioLife Solutions Major Business
9.2.3 BioLife Solutions Cell and Advanced Therapies Supply Chain Management Product and Services
9.2.4 BioLife Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 BioLife Solutions Recent Developments/Updates
9.2.6 BioLife Solutions Competitive Strengths & Weaknesses
9.3 Azenta
9.3.1 Azenta Details
9.3.2 Azenta Major Business
9.3.3 Azenta Cell and Advanced Therapies Supply Chain Management Product and Services
9.3.4 Azenta Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Azenta Recent Developments/Updates
9.3.6 Azenta Competitive Strengths & Weaknesses
9.4 Modality Solutions
9.4.1 Modality Solutions Details
9.4.2 Modality Solutions Major Business
9.4.3 Modality Solutions Cell and Advanced Therapies Supply Chain Management Product and Services
9.4.4 Modality Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Modality Solutions Recent Developments/Updates
9.4.6 Modality Solutions Competitive Strengths & Weaknesses
9.5 PCA
9.5.1 PCA Details
9.5.2 PCA Major Business
9.5.3 PCA Cell and Advanced Therapies Supply Chain Management Product and Services
9.5.4 PCA Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 PCA Recent Developments/Updates
9.5.6 PCA Competitive Strengths & Weaknesses
9.6 QuickSTAT
9.6.1 QuickSTAT Details
9.6.2 QuickSTAT Major Business
9.6.3 QuickSTAT Cell and Advanced Therapies Supply Chain Management Product and Services
9.6.4 QuickSTAT Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 QuickSTAT Recent Developments/Updates
9.6.6 QuickSTAT Competitive Strengths & Weaknesses
9.7 Be The Match BioTherapies
9.7.1 Be The Match BioTherapies Details
9.7.2 Be The Match BioTherapies Major Business
9.7.3 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product and Services
9.7.4 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Be The Match BioTherapies Recent Developments/Updates
9.7.6 Be The Match BioTherapies Competitive Strengths & Weaknesses
9.8 Brooks Life Sciences
9.8.1 Brooks Life Sciences Details
9.8.2 Brooks Life Sciences Major Business
9.8.3 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product and Services
9.8.4 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Brooks Life Sciences Recent Developments/Updates
9.8.6 Brooks Life Sciences Competitive Strengths & Weaknesses
9.9 Cryoport
9.9.1 Cryoport Details
9.9.2 Cryoport Major Business
9.9.3 Cryoport Cell and Advanced Therapies Supply Chain Management Product and Services
9.9.4 Cryoport Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Cryoport Recent Developments/Updates
9.9.6 Cryoport Competitive Strengths & Weaknesses
9.10 Haemonetics
9.10.1 Haemonetics Details
9.10.2 Haemonetics Major Business
9.10.3 Haemonetics Cell and Advanced Therapies Supply Chain Management Product and Services
9.10.4 Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Haemonetics Recent Developments/Updates
9.10.6 Haemonetics Competitive Strengths & Weaknesses
9.11 Hypertrust Patient Data Care
9.11.1 Hypertrust Patient Data Care Details
9.11.2 Hypertrust Patient Data Care Major Business
9.11.3 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product and Services
9.11.4 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Hypertrust Patient Data Care Recent Developments/Updates
9.11.6 Hypertrust Patient Data Care Competitive Strengths & Weaknesses
9.12 Lykan Bioscience
9.12.1 Lykan Bioscience Details
9.12.2 Lykan Bioscience Major Business
9.12.3 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product and Services
9.12.4 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Lykan Bioscience Recent Developments/Updates
9.12.6 Lykan Bioscience Competitive Strengths & Weaknesses
9.13 MAK-SYSTEM
9.13.1 MAK-SYSTEM Details
9.13.2 MAK-SYSTEM Major Business
9.13.3 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product and Services
9.13.4 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 MAK-SYSTEM Recent Developments/Updates
9.13.6 MAK-SYSTEM Competitive Strengths & Weaknesses
9.14 MasterControl
9.14.1 MasterControl Details
9.14.2 MasterControl Major Business
9.14.3 MasterControl Cell and Advanced Therapies Supply Chain Management Product and Services
9.14.4 MasterControl Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 MasterControl Recent Developments/Updates
9.14.6 MasterControl Competitive Strengths & Weaknesses
9.15 SAP
9.15.1 SAP Details
9.15.2 SAP Major Business
9.15.3 SAP Cell and Advanced Therapies Supply Chain Management Product and Services
9.15.4 SAP Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 SAP Recent Developments/Updates
9.15.6 SAP Competitive Strengths & Weaknesses
9.16 SAVSU Technologies
9.16.1 SAVSU Technologies Details
9.16.2 SAVSU Technologies Major Business
9.16.3 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product and Services
9.16.4 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 SAVSU Technologies Recent Developments/Updates
9.16.6 SAVSU Technologies Competitive Strengths & Weaknesses
9.17 sedApta Group
9.17.1 sedApta Group Details
9.17.2 sedApta Group Major Business
9.17.3 sedApta Group Cell and Advanced Therapies Supply Chain Management Product and Services
9.17.4 sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 sedApta Group Recent Developments/Updates
9.17.6 sedApta Group Competitive Strengths & Weaknesses
9.18 Stafa Cellular Therapy
9.18.1 Stafa Cellular Therapy Details
9.18.2 Stafa Cellular Therapy Major Business
9.18.3 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product and Services
9.18.4 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Stafa Cellular Therapy Recent Developments/Updates
9.18.6 Stafa Cellular Therapy Competitive Strengths & Weaknesses
9.19 Title21 Health Solutions
9.19.1 Title21 Health Solutions Details
9.19.2 Title21 Health Solutions Major Business
9.19.3 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product and Services
9.19.4 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Title21 Health Solutions Recent Developments/Updates
9.19.6 Title21 Health Solutions Competitive Strengths & Weaknesses
9.20 TraceLink
9.20.1 TraceLink Details
9.20.2 TraceLink Major Business
9.20.3 TraceLink Cell and Advanced Therapies Supply Chain Management Product and Services
9.20.4 TraceLink Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 TraceLink Recent Developments/Updates
9.20.6 TraceLink Competitive Strengths & Weaknesses
9.21 TrakCel
9.21.1 TrakCel Details
9.21.2 TrakCel Major Business
9.21.3 TrakCel Cell and Advanced Therapies Supply Chain Management Product and Services
9.21.4 TrakCel Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 TrakCel Recent Developments/Updates
9.21.6 TrakCel Competitive Strengths & Weaknesses
9.22 Vineti
9.22.1 Vineti Details
9.22.2 Vineti Major Business
9.22.3 Vineti Cell and Advanced Therapies Supply Chain Management Product and Services
9.22.4 Vineti Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Vineti Recent Developments/Updates
9.22.6 Vineti Competitive Strengths & Weaknesses
9.23 Lonza
9.23.1 Lonza Details
9.23.2 Lonza Major Business
9.23.3 Lonza Cell and Advanced Therapies Supply Chain Management Product and Services
9.23.4 Lonza Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Lonza Recent Developments/Updates
9.23.6 Lonza Competitive Strengths & Weaknesses
9.24 Sartorius
9.24.1 Sartorius Details
9.24.2 Sartorius Major Business
9.24.3 Sartorius Cell and Advanced Therapies Supply Chain Management Product and Services
9.24.4 Sartorius Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Sartorius Recent Developments/Updates
9.24.6 Sartorius Competitive Strengths & Weaknesses
9.25 BioOutsource
9.25.1 BioOutsource Details
9.25.2 BioOutsource Major Business
9.25.3 BioOutsource Cell and Advanced Therapies Supply Chain Management Product and Services
9.25.4 BioOutsource Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 BioOutsource Recent Developments/Updates
9.25.6 BioOutsource Competitive Strengths & Weaknesses
9.26 GenScript
9.26.1 GenScript Details
9.26.2 GenScript Major Business
9.26.3 GenScript Cell and Advanced Therapies Supply Chain Management Product and Services
9.26.4 GenScript Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 GenScript Recent Developments/Updates
9.26.6 GenScript Competitive Strengths & Weaknesses
9.27 WuXi AppTec
9.27.1 WuXi AppTec Details
9.27.2 WuXi AppTec Major Business
9.27.3 WuXi AppTec Cell and Advanced Therapies Supply Chain Management Product and Services
9.27.4 WuXi AppTec Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 WuXi AppTec Recent Developments/Updates
9.27.6 WuXi AppTec Competitive Strengths & Weaknesses
9.28 Pharmaron
9.28.1 Pharmaron Details
9.28.2 Pharmaron Major Business
9.28.3 Pharmaron Cell and Advanced Therapies Supply Chain Management Product and Services
9.28.4 Pharmaron Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Pharmaron Recent Developments/Updates
9.28.6 Pharmaron Competitive Strengths & Weaknesses
9.29 JOINN
9.29.1 JOINN Details
9.29.2 JOINN Major Business
9.29.3 JOINN Cell and Advanced Therapies Supply Chain Management Product and Services
9.29.4 JOINN Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 JOINN Recent Developments/Updates
9.29.6 JOINN Competitive Strengths & Weaknesses
9.30 NIPRO
9.30.1 NIPRO Details
9.30.2 NIPRO Major Business
9.30.3 NIPRO Cell and Advanced Therapies Supply Chain Management Product and Services
9.30.4 NIPRO Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 NIPRO Recent Developments/Updates
9.30.6 NIPRO Competitive Strengths & Weaknesses
9.31 Kawasaki Heavy Industries
9.31.1 Kawasaki Heavy Industries Details
9.31.2 Kawasaki Heavy Industries Major Business
9.31.3 Kawasaki Heavy Industries Cell and Advanced Therapies Supply Chain Management Product and Services
9.31.4 Kawasaki Heavy Industries Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Kawasaki Heavy Industries Recent Developments/Updates
9.31.6 Kawasaki Heavy Industries Competitive Strengths & Weaknesses
9.32 JCR Pharmaceuticals
9.32.1 JCR Pharmaceuticals Details
9.32.2 JCR Pharmaceuticals Major Business
9.32.3 JCR Pharmaceuticals Cell and Advanced Therapies Supply Chain Management Product and Services
9.32.4 JCR Pharmaceuticals Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 JCR Pharmaceuticals Recent Developments/Updates
9.32.6 JCR Pharmaceuticals Competitive Strengths & Weaknesses
9.33 Fujifilm Cellular Dynamics
9.33.1 Fujifilm Cellular Dynamics Details
9.33.2 Fujifilm Cellular Dynamics Major Business
9.33.3 Fujifilm Cellular Dynamics Cell and Advanced Therapies Supply Chain Management Product and Services
9.33.4 Fujifilm Cellular Dynamics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 Fujifilm Cellular Dynamics Recent Developments/Updates
9.33.6 Fujifilm Cellular Dynamics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cell and Advanced Therapies Supply Chain Management Industry Chain
10.2 Cell and Advanced Therapies Supply Chain Management Upstream Analysis
10.3 Cell and Advanced Therapies Supply Chain Management Midstream Analysis
10.4 Cell and Advanced Therapies Supply Chain Management Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Cell and Advanced Therapies Supply Chain Management Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Advanced Therapies Supply Chain Management Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Advanced Therapies Supply Chain Management Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Advanced Therapies Supply Chain Management Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Cell and Advanced Therapies Supply Chain Management Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Cell and Advanced Therapies Supply Chain Management Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Cell and Advanced Therapies Supply Chain Management Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Advanced Therapies Supply Chain Management Players in 2025
Table 12. World Cell and Advanced Therapies Supply Chain Management Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Cell and Advanced Therapies Supply Chain Management Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Advanced Therapies Supply Chain Management Players
Table 15. Cell and Advanced Therapies Supply Chain Management Market: Company Product Type Footprint
Table 16. Cell and Advanced Therapies Supply Chain Management Market: Company Product Application Footprint
Table 17. Cell and Advanced Therapies Supply Chain Management Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Advanced Therapies Supply Chain Management Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Cell and Advanced Therapies Supply Chain Management Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Cell and Advanced Therapies Supply Chain Management Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Advanced Therapies Supply Chain Management Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Cell and Advanced Therapies Supply Chain Management Revenue Market Share (2021-2026)
Table 23. China Based Cell and Advanced Therapies Supply Chain Management Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Advanced Therapies Supply Chain Management Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Cell and Advanced Therapies Supply Chain Management Revenue Market Share (2021-2026)
Table 26. Rest of World Based Cell and Advanced Therapies Supply Chain Management Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Cell and Advanced Therapies Supply Chain Management Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Cell and Advanced Therapies Supply Chain Management Revenue Market Share (2021-2026)
Table 29. World Cell and Advanced Therapies Supply Chain Management Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Cell and Advanced Therapies Supply Chain Management Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Cell and Advanced Therapies Supply Chain Management Market Size by Type (2027-2032) & (USD Million)
Table 32. World Cell and Advanced Therapies Supply Chain Management Market Size by Supply Chain, (USD Million), 2021 & 2025 & 2032
Table 33. World Cell and Advanced Therapies Supply Chain Management Market Size Value by Supply Chain (2021-2026) & (USD Million)
Table 34. World Cell and Advanced Therapies Supply Chain Management Market Size by Supply Chain (2027-2032) & (USD Million)
Table 35. World Cell and Advanced Therapies Supply Chain Management Market Size by Temperature, (USD Million), 2021 & 2025 & 2032
Table 36. World Cell and Advanced Therapies Supply Chain Management Market Size Value by Temperature (2021-2026) & (USD Million)
Table 37. World Cell and Advanced Therapies Supply Chain Management Market Size by Temperature (2027-2032) & (USD Million)
Table 38. World Cell and Advanced Therapies Supply Chain Management Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026) & (USD Million)
Table 40. World Cell and Advanced Therapies Supply Chain Management Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Cell and Advanced Therapies Supply Chain Management Product and Services
Table 44. Thermo Fisher Scientific Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. BioLife Solutions Basic Information, Manufacturing Base and Competitors
Table 48. BioLife Solutions Major Business
Table 49. BioLife Solutions Cell and Advanced Therapies Supply Chain Management Product and Services
Table 50. BioLife Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. BioLife Solutions Recent Developments/Updates
Table 52. BioLife Solutions Competitive Strengths & Weaknesses
Table 53. Azenta Basic Information, Manufacturing Base and Competitors
Table 54. Azenta Major Business
Table 55. Azenta Cell and Advanced Therapies Supply Chain Management Product and Services
Table 56. Azenta Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Azenta Recent Developments/Updates
Table 58. Azenta Competitive Strengths & Weaknesses
Table 59. Modality Solutions Basic Information, Manufacturing Base and Competitors
Table 60. Modality Solutions Major Business
Table 61. Modality Solutions Cell and Advanced Therapies Supply Chain Management Product and Services
Table 62. Modality Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Modality Solutions Recent Developments/Updates
Table 64. Modality Solutions Competitive Strengths & Weaknesses
Table 65. PCA Basic Information, Manufacturing Base and Competitors
Table 66. PCA Major Business
Table 67. PCA Cell and Advanced Therapies Supply Chain Management Product and Services
Table 68. PCA Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. PCA Recent Developments/Updates
Table 70. PCA Competitive Strengths & Weaknesses
Table 71. QuickSTAT Basic Information, Manufacturing Base and Competitors
Table 72. QuickSTAT Major Business
Table 73. QuickSTAT Cell and Advanced Therapies Supply Chain Management Product and Services
Table 74. QuickSTAT Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. QuickSTAT Recent Developments/Updates
Table 76. QuickSTAT Competitive Strengths & Weaknesses
Table 77. Be The Match BioTherapies Basic Information, Manufacturing Base and Competitors
Table 78. Be The Match BioTherapies Major Business
Table 79. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product and Services
Table 80. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Be The Match BioTherapies Recent Developments/Updates
Table 82. Be The Match BioTherapies Competitive Strengths & Weaknesses
Table 83. Brooks Life Sciences Basic Information, Manufacturing Base and Competitors
Table 84. Brooks Life Sciences Major Business
Table 85. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product and Services
Table 86. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Brooks Life Sciences Recent Developments/Updates
Table 88. Brooks Life Sciences Competitive Strengths & Weaknesses
Table 89. Cryoport Basic Information, Manufacturing Base and Competitors
Table 90. Cryoport Major Business
Table 91. Cryoport Cell and Advanced Therapies Supply Chain Management Product and Services
Table 92. Cryoport Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Cryoport Recent Developments/Updates
Table 94. Cryoport Competitive Strengths & Weaknesses
Table 95. Haemonetics Basic Information, Manufacturing Base and Competitors
Table 96. Haemonetics Major Business
Table 97. Haemonetics Cell and Advanced Therapies Supply Chain Management Product and Services
Table 98. Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Haemonetics Recent Developments/Updates
Table 100. Haemonetics Competitive Strengths & Weaknesses
Table 101. Hypertrust Patient Data Care Basic Information, Manufacturing Base and Competitors
Table 102. Hypertrust Patient Data Care Major Business
Table 103. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product and Services
Table 104. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Hypertrust Patient Data Care Recent Developments/Updates
Table 106. Hypertrust Patient Data Care Competitive Strengths & Weaknesses
Table 107. Lykan Bioscience Basic Information, Manufacturing Base and Competitors
Table 108. Lykan Bioscience Major Business
Table 109. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product and Services
Table 110. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Lykan Bioscience Recent Developments/Updates
Table 112. Lykan Bioscience Competitive Strengths & Weaknesses
Table 113. MAK-SYSTEM Basic Information, Manufacturing Base and Competitors
Table 114. MAK-SYSTEM Major Business
Table 115. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product and Services
Table 116. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. MAK-SYSTEM Recent Developments/Updates
Table 118. MAK-SYSTEM Competitive Strengths & Weaknesses
Table 119. MasterControl Basic Information, Manufacturing Base and Competitors
Table 120. MasterControl Major Business
Table 121. MasterControl Cell and Advanced Therapies Supply Chain Management Product and Services
Table 122. MasterControl Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. MasterControl Recent Developments/Updates
Table 124. MasterControl Competitive Strengths & Weaknesses
Table 125. SAP Basic Information, Manufacturing Base and Competitors
Table 126. SAP Major Business
Table 127. SAP Cell and Advanced Therapies Supply Chain Management Product and Services
Table 128. SAP Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. SAP Recent Developments/Updates
Table 130. SAP Competitive Strengths & Weaknesses
Table 131. SAVSU Technologies Basic Information, Manufacturing Base and Competitors
Table 132. SAVSU Technologies Major Business
Table 133. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product and Services
Table 134. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. SAVSU Technologies Recent Developments/Updates
Table 136. SAVSU Technologies Competitive Strengths & Weaknesses
Table 137. sedApta Group Basic Information, Manufacturing Base and Competitors
Table 138. sedApta Group Major Business
Table 139. sedApta Group Cell and Advanced Therapies Supply Chain Management Product and Services
Table 140. sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. sedApta Group Recent Developments/Updates
Table 142. sedApta Group Competitive Strengths & Weaknesses
Table 143. Stafa Cellular Therapy Basic Information, Manufacturing Base and Competitors
Table 144. Stafa Cellular Therapy Major Business
Table 145. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product and Services
Table 146. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Stafa Cellular Therapy Recent Developments/Updates
Table 148. Stafa Cellular Therapy Competitive Strengths & Weaknesses
Table 149. Title21 Health Solutions Basic Information, Manufacturing Base and Competitors
Table 150. Title21 Health Solutions Major Business
Table 151. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product and Services
Table 152. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Title21 Health Solutions Recent Developments/Updates
Table 154. Title21 Health Solutions Competitive Strengths & Weaknesses
Table 155. TraceLink Basic Information, Manufacturing Base and Competitors
Table 156. TraceLink Major Business
Table 157. TraceLink Cell and Advanced Therapies Supply Chain Management Product and Services
Table 158. TraceLink Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. TraceLink Recent Developments/Updates
Table 160. TraceLink Competitive Strengths & Weaknesses
Table 161. TrakCel Basic Information, Manufacturing Base and Competitors
Table 162. TrakCel Major Business
Table 163. TrakCel Cell and Advanced Therapies Supply Chain Management Product and Services
Table 164. TrakCel Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. TrakCel Recent Developments/Updates
Table 166. TrakCel Competitive Strengths & Weaknesses
Table 167. Vineti Basic Information, Manufacturing Base and Competitors
Table 168. Vineti Major Business
Table 169. Vineti Cell and Advanced Therapies Supply Chain Management Product and Services
Table 170. Vineti Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Vineti Recent Developments/Updates
Table 172. Vineti Competitive Strengths & Weaknesses
Table 173. Lonza Basic Information, Manufacturing Base and Competitors
Table 174. Lonza Major Business
Table 175. Lonza Cell and Advanced Therapies Supply Chain Management Product and Services
Table 176. Lonza Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Lonza Recent Developments/Updates
Table 178. Lonza Competitive Strengths & Weaknesses
Table 179. Sartorius Basic Information, Manufacturing Base and Competitors
Table 180. Sartorius Major Business
Table 181. Sartorius Cell and Advanced Therapies Supply Chain Management Product and Services
Table 182. Sartorius Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Sartorius Recent Developments/Updates
Table 184. Sartorius Competitive Strengths & Weaknesses
Table 185. BioOutsource Basic Information, Manufacturing Base and Competitors
Table 186. BioOutsource Major Business
Table 187. BioOutsource Cell and Advanced Therapies Supply Chain Management Product and Services
Table 188. BioOutsource Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. BioOutsource Recent Developments/Updates
Table 190. BioOutsource Competitive Strengths & Weaknesses
Table 191. GenScript Basic Information, Manufacturing Base and Competitors
Table 192. GenScript Major Business
Table 193. GenScript Cell and Advanced Therapies Supply Chain Management Product and Services
Table 194. GenScript Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. GenScript Recent Developments/Updates
Table 196. GenScript Competitive Strengths & Weaknesses
Table 197. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 198. WuXi AppTec Major Business
Table 199. WuXi AppTec Cell and Advanced Therapies Supply Chain Management Product and Services
Table 200. WuXi AppTec Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. WuXi AppTec Recent Developments/Updates
Table 202. WuXi AppTec Competitive Strengths & Weaknesses
Table 203. Pharmaron Basic Information, Manufacturing Base and Competitors
Table 204. Pharmaron Major Business
Table 205. Pharmaron Cell and Advanced Therapies Supply Chain Management Product and Services
Table 206. Pharmaron Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Pharmaron Recent Developments/Updates
Table 208. Pharmaron Competitive Strengths & Weaknesses
Table 209. JOINN Basic Information, Manufacturing Base and Competitors
Table 210. JOINN Major Business
Table 211. JOINN Cell and Advanced Therapies Supply Chain Management Product and Services
Table 212. JOINN Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. JOINN Recent Developments/Updates
Table 214. JOINN Competitive Strengths & Weaknesses
Table 215. NIPRO Basic Information, Manufacturing Base and Competitors
Table 216. NIPRO Major Business
Table 217. NIPRO Cell and Advanced Therapies Supply Chain Management Product and Services
Table 218. NIPRO Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. NIPRO Recent Developments/Updates
Table 220. NIPRO Competitive Strengths & Weaknesses
Table 221. Kawasaki Heavy Industries Basic Information, Manufacturing Base and Competitors
Table 222. Kawasaki Heavy Industries Major Business
Table 223. Kawasaki Heavy Industries Cell and Advanced Therapies Supply Chain Management Product and Services
Table 224. Kawasaki Heavy Industries Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Kawasaki Heavy Industries Recent Developments/Updates
Table 226. Kawasaki Heavy Industries Competitive Strengths & Weaknesses
Table 227. JCR Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 228. JCR Pharmaceuticals Major Business
Table 229. JCR Pharmaceuticals Cell and Advanced Therapies Supply Chain Management Product and Services
Table 230. JCR Pharmaceuticals Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. JCR Pharmaceuticals Recent Developments/Updates
Table 232. JCR Pharmaceuticals Competitive Strengths & Weaknesses
Table 233. Fujifilm Cellular Dynamics Basic Information, Manufacturing Base and Competitors
Table 234. Fujifilm Cellular Dynamics Major Business
Table 235. Fujifilm Cellular Dynamics Cell and Advanced Therapies Supply Chain Management Product and Services
Table 236. Fujifilm Cellular Dynamics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. Fujifilm Cellular Dynamics Recent Developments/Updates
Table 238. Fujifilm Cellular Dynamics Competitive Strengths & Weaknesses
Table 239. Global Key Players of Cell and Advanced Therapies Supply Chain Management Upstream (Raw Materials)
Table 240. Global Cell and Advanced Therapies Supply Chain Management Typical Customers
Table 1. World Cell and Advanced Therapies Supply Chain Management Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Advanced Therapies Supply Chain Management Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Advanced Therapies Supply Chain Management Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Advanced Therapies Supply Chain Management Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Cell and Advanced Therapies Supply Chain Management Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Cell and Advanced Therapies Supply Chain Management Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Cell and Advanced Therapies Supply Chain Management Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Advanced Therapies Supply Chain Management Players in 2025
Table 12. World Cell and Advanced Therapies Supply Chain Management Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Cell and Advanced Therapies Supply Chain Management Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Advanced Therapies Supply Chain Management Players
Table 15. Cell and Advanced Therapies Supply Chain Management Market: Company Product Type Footprint
Table 16. Cell and Advanced Therapies Supply Chain Management Market: Company Product Application Footprint
Table 17. Cell and Advanced Therapies Supply Chain Management Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Advanced Therapies Supply Chain Management Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Cell and Advanced Therapies Supply Chain Management Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Cell and Advanced Therapies Supply Chain Management Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Advanced Therapies Supply Chain Management Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Cell and Advanced Therapies Supply Chain Management Revenue Market Share (2021-2026)
Table 23. China Based Cell and Advanced Therapies Supply Chain Management Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Advanced Therapies Supply Chain Management Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Cell and Advanced Therapies Supply Chain Management Revenue Market Share (2021-2026)
Table 26. Rest of World Based Cell and Advanced Therapies Supply Chain Management Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Cell and Advanced Therapies Supply Chain Management Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Cell and Advanced Therapies Supply Chain Management Revenue Market Share (2021-2026)
Table 29. World Cell and Advanced Therapies Supply Chain Management Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Cell and Advanced Therapies Supply Chain Management Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Cell and Advanced Therapies Supply Chain Management Market Size by Type (2027-2032) & (USD Million)
Table 32. World Cell and Advanced Therapies Supply Chain Management Market Size by Supply Chain, (USD Million), 2021 & 2025 & 2032
Table 33. World Cell and Advanced Therapies Supply Chain Management Market Size Value by Supply Chain (2021-2026) & (USD Million)
Table 34. World Cell and Advanced Therapies Supply Chain Management Market Size by Supply Chain (2027-2032) & (USD Million)
Table 35. World Cell and Advanced Therapies Supply Chain Management Market Size by Temperature, (USD Million), 2021 & 2025 & 2032
Table 36. World Cell and Advanced Therapies Supply Chain Management Market Size Value by Temperature (2021-2026) & (USD Million)
Table 37. World Cell and Advanced Therapies Supply Chain Management Market Size by Temperature (2027-2032) & (USD Million)
Table 38. World Cell and Advanced Therapies Supply Chain Management Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Cell and Advanced Therapies Supply Chain Management Market Size by Application (2021-2026) & (USD Million)
Table 40. World Cell and Advanced Therapies Supply Chain Management Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific Cell and Advanced Therapies Supply Chain Management Product and Services
Table 44. Thermo Fisher Scientific Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. BioLife Solutions Basic Information, Manufacturing Base and Competitors
Table 48. BioLife Solutions Major Business
Table 49. BioLife Solutions Cell and Advanced Therapies Supply Chain Management Product and Services
Table 50. BioLife Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. BioLife Solutions Recent Developments/Updates
Table 52. BioLife Solutions Competitive Strengths & Weaknesses
Table 53. Azenta Basic Information, Manufacturing Base and Competitors
Table 54. Azenta Major Business
Table 55. Azenta Cell and Advanced Therapies Supply Chain Management Product and Services
Table 56. Azenta Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Azenta Recent Developments/Updates
Table 58. Azenta Competitive Strengths & Weaknesses
Table 59. Modality Solutions Basic Information, Manufacturing Base and Competitors
Table 60. Modality Solutions Major Business
Table 61. Modality Solutions Cell and Advanced Therapies Supply Chain Management Product and Services
Table 62. Modality Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Modality Solutions Recent Developments/Updates
Table 64. Modality Solutions Competitive Strengths & Weaknesses
Table 65. PCA Basic Information, Manufacturing Base and Competitors
Table 66. PCA Major Business
Table 67. PCA Cell and Advanced Therapies Supply Chain Management Product and Services
Table 68. PCA Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. PCA Recent Developments/Updates
Table 70. PCA Competitive Strengths & Weaknesses
Table 71. QuickSTAT Basic Information, Manufacturing Base and Competitors
Table 72. QuickSTAT Major Business
Table 73. QuickSTAT Cell and Advanced Therapies Supply Chain Management Product and Services
Table 74. QuickSTAT Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. QuickSTAT Recent Developments/Updates
Table 76. QuickSTAT Competitive Strengths & Weaknesses
Table 77. Be The Match BioTherapies Basic Information, Manufacturing Base and Competitors
Table 78. Be The Match BioTherapies Major Business
Table 79. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product and Services
Table 80. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Be The Match BioTherapies Recent Developments/Updates
Table 82. Be The Match BioTherapies Competitive Strengths & Weaknesses
Table 83. Brooks Life Sciences Basic Information, Manufacturing Base and Competitors
Table 84. Brooks Life Sciences Major Business
Table 85. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product and Services
Table 86. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Brooks Life Sciences Recent Developments/Updates
Table 88. Brooks Life Sciences Competitive Strengths & Weaknesses
Table 89. Cryoport Basic Information, Manufacturing Base and Competitors
Table 90. Cryoport Major Business
Table 91. Cryoport Cell and Advanced Therapies Supply Chain Management Product and Services
Table 92. Cryoport Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Cryoport Recent Developments/Updates
Table 94. Cryoport Competitive Strengths & Weaknesses
Table 95. Haemonetics Basic Information, Manufacturing Base and Competitors
Table 96. Haemonetics Major Business
Table 97. Haemonetics Cell and Advanced Therapies Supply Chain Management Product and Services
Table 98. Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Haemonetics Recent Developments/Updates
Table 100. Haemonetics Competitive Strengths & Weaknesses
Table 101. Hypertrust Patient Data Care Basic Information, Manufacturing Base and Competitors
Table 102. Hypertrust Patient Data Care Major Business
Table 103. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product and Services
Table 104. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Hypertrust Patient Data Care Recent Developments/Updates
Table 106. Hypertrust Patient Data Care Competitive Strengths & Weaknesses
Table 107. Lykan Bioscience Basic Information, Manufacturing Base and Competitors
Table 108. Lykan Bioscience Major Business
Table 109. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product and Services
Table 110. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Lykan Bioscience Recent Developments/Updates
Table 112. Lykan Bioscience Competitive Strengths & Weaknesses
Table 113. MAK-SYSTEM Basic Information, Manufacturing Base and Competitors
Table 114. MAK-SYSTEM Major Business
Table 115. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product and Services
Table 116. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. MAK-SYSTEM Recent Developments/Updates
Table 118. MAK-SYSTEM Competitive Strengths & Weaknesses
Table 119. MasterControl Basic Information, Manufacturing Base and Competitors
Table 120. MasterControl Major Business
Table 121. MasterControl Cell and Advanced Therapies Supply Chain Management Product and Services
Table 122. MasterControl Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. MasterControl Recent Developments/Updates
Table 124. MasterControl Competitive Strengths & Weaknesses
Table 125. SAP Basic Information, Manufacturing Base and Competitors
Table 126. SAP Major Business
Table 127. SAP Cell and Advanced Therapies Supply Chain Management Product and Services
Table 128. SAP Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. SAP Recent Developments/Updates
Table 130. SAP Competitive Strengths & Weaknesses
Table 131. SAVSU Technologies Basic Information, Manufacturing Base and Competitors
Table 132. SAVSU Technologies Major Business
Table 133. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product and Services
Table 134. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. SAVSU Technologies Recent Developments/Updates
Table 136. SAVSU Technologies Competitive Strengths & Weaknesses
Table 137. sedApta Group Basic Information, Manufacturing Base and Competitors
Table 138. sedApta Group Major Business
Table 139. sedApta Group Cell and Advanced Therapies Supply Chain Management Product and Services
Table 140. sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. sedApta Group Recent Developments/Updates
Table 142. sedApta Group Competitive Strengths & Weaknesses
Table 143. Stafa Cellular Therapy Basic Information, Manufacturing Base and Competitors
Table 144. Stafa Cellular Therapy Major Business
Table 145. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product and Services
Table 146. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Stafa Cellular Therapy Recent Developments/Updates
Table 148. Stafa Cellular Therapy Competitive Strengths & Weaknesses
Table 149. Title21 Health Solutions Basic Information, Manufacturing Base and Competitors
Table 150. Title21 Health Solutions Major Business
Table 151. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product and Services
Table 152. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Title21 Health Solutions Recent Developments/Updates
Table 154. Title21 Health Solutions Competitive Strengths & Weaknesses
Table 155. TraceLink Basic Information, Manufacturing Base and Competitors
Table 156. TraceLink Major Business
Table 157. TraceLink Cell and Advanced Therapies Supply Chain Management Product and Services
Table 158. TraceLink Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. TraceLink Recent Developments/Updates
Table 160. TraceLink Competitive Strengths & Weaknesses
Table 161. TrakCel Basic Information, Manufacturing Base and Competitors
Table 162. TrakCel Major Business
Table 163. TrakCel Cell and Advanced Therapies Supply Chain Management Product and Services
Table 164. TrakCel Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. TrakCel Recent Developments/Updates
Table 166. TrakCel Competitive Strengths & Weaknesses
Table 167. Vineti Basic Information, Manufacturing Base and Competitors
Table 168. Vineti Major Business
Table 169. Vineti Cell and Advanced Therapies Supply Chain Management Product and Services
Table 170. Vineti Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Vineti Recent Developments/Updates
Table 172. Vineti Competitive Strengths & Weaknesses
Table 173. Lonza Basic Information, Manufacturing Base and Competitors
Table 174. Lonza Major Business
Table 175. Lonza Cell and Advanced Therapies Supply Chain Management Product and Services
Table 176. Lonza Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Lonza Recent Developments/Updates
Table 178. Lonza Competitive Strengths & Weaknesses
Table 179. Sartorius Basic Information, Manufacturing Base and Competitors
Table 180. Sartorius Major Business
Table 181. Sartorius Cell and Advanced Therapies Supply Chain Management Product and Services
Table 182. Sartorius Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Sartorius Recent Developments/Updates
Table 184. Sartorius Competitive Strengths & Weaknesses
Table 185. BioOutsource Basic Information, Manufacturing Base and Competitors
Table 186. BioOutsource Major Business
Table 187. BioOutsource Cell and Advanced Therapies Supply Chain Management Product and Services
Table 188. BioOutsource Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. BioOutsource Recent Developments/Updates
Table 190. BioOutsource Competitive Strengths & Weaknesses
Table 191. GenScript Basic Information, Manufacturing Base and Competitors
Table 192. GenScript Major Business
Table 193. GenScript Cell and Advanced Therapies Supply Chain Management Product and Services
Table 194. GenScript Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. GenScript Recent Developments/Updates
Table 196. GenScript Competitive Strengths & Weaknesses
Table 197. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 198. WuXi AppTec Major Business
Table 199. WuXi AppTec Cell and Advanced Therapies Supply Chain Management Product and Services
Table 200. WuXi AppTec Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. WuXi AppTec Recent Developments/Updates
Table 202. WuXi AppTec Competitive Strengths & Weaknesses
Table 203. Pharmaron Basic Information, Manufacturing Base and Competitors
Table 204. Pharmaron Major Business
Table 205. Pharmaron Cell and Advanced Therapies Supply Chain Management Product and Services
Table 206. Pharmaron Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Pharmaron Recent Developments/Updates
Table 208. Pharmaron Competitive Strengths & Weaknesses
Table 209. JOINN Basic Information, Manufacturing Base and Competitors
Table 210. JOINN Major Business
Table 211. JOINN Cell and Advanced Therapies Supply Chain Management Product and Services
Table 212. JOINN Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. JOINN Recent Developments/Updates
Table 214. JOINN Competitive Strengths & Weaknesses
Table 215. NIPRO Basic Information, Manufacturing Base and Competitors
Table 216. NIPRO Major Business
Table 217. NIPRO Cell and Advanced Therapies Supply Chain Management Product and Services
Table 218. NIPRO Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. NIPRO Recent Developments/Updates
Table 220. NIPRO Competitive Strengths & Weaknesses
Table 221. Kawasaki Heavy Industries Basic Information, Manufacturing Base and Competitors
Table 222. Kawasaki Heavy Industries Major Business
Table 223. Kawasaki Heavy Industries Cell and Advanced Therapies Supply Chain Management Product and Services
Table 224. Kawasaki Heavy Industries Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Kawasaki Heavy Industries Recent Developments/Updates
Table 226. Kawasaki Heavy Industries Competitive Strengths & Weaknesses
Table 227. JCR Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 228. JCR Pharmaceuticals Major Business
Table 229. JCR Pharmaceuticals Cell and Advanced Therapies Supply Chain Management Product and Services
Table 230. JCR Pharmaceuticals Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. JCR Pharmaceuticals Recent Developments/Updates
Table 232. JCR Pharmaceuticals Competitive Strengths & Weaknesses
Table 233. Fujifilm Cellular Dynamics Basic Information, Manufacturing Base and Competitors
Table 234. Fujifilm Cellular Dynamics Major Business
Table 235. Fujifilm Cellular Dynamics Cell and Advanced Therapies Supply Chain Management Product and Services
Table 236. Fujifilm Cellular Dynamics Cell and Advanced Therapies Supply Chain Management Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. Fujifilm Cellular Dynamics Recent Developments/Updates
Table 238. Fujifilm Cellular Dynamics Competitive Strengths & Weaknesses
Table 239. Global Key Players of Cell and Advanced Therapies Supply Chain Management Upstream (Raw Materials)
Table 240. Global Cell and Advanced Therapies Supply Chain Management Typical Customers
LIST OF FIGURES
Figure 1. Cell and Advanced Therapies Supply Chain Management Picture
Figure 2. World Cell and Advanced Therapies Supply Chain Management Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Cell and Advanced Therapies Supply Chain Management Total Revenue (2021-2032) & (USD Million)
Figure 4. World Cell and Advanced Therapies Supply Chain Management Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 13. Cell and Advanced Therapies Supply Chain Management Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 16. World Cell and Advanced Therapies Supply Chain Management Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 18. China Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 23. India Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Cell and Advanced Therapies Supply Chain Management by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Advanced Therapies Supply Chain Management Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Advanced Therapies Supply Chain Management Markets in 2025
Figure 27. United States VS China: Cell and Advanced Therapies Supply Chain Management Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Cell and Advanced Therapies Supply Chain Management Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Cell and Advanced Therapies Supply Chain Management Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type in 2025
Figure 31. Cloud
Figure 32. On-premises
Figure 33. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2021-2032)
Figure 34. World Cell and Advanced Therapies Supply Chain Management Market Size by Supply Chain, (USD Million), 2021 & 2025 & 2032
Figure 35. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Supply Chain in 2025
Figure 36. Collection
Figure 37. Production and Manufacturing
Figure 38. Cold Chain Transportation
Figure 39. Storage
Figure 40. Clinical Use
Figure 41. Others
Figure 42. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Supply Chain (2021-2032)
Figure 43. World Cell and Advanced Therapies Supply Chain Management Market Size by Temperature, (USD Million), 2021 & 2025 & 2032
Figure 44. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Temperature in 2025
Figure 45. Ambient Temperature (15-25°C)
Figure 46. Refrigerated (2-8°C)
Figure 47. Frozen (-20°C)
Figure 48. Deep-frozen (-80°C)
Figure 49. Cryogenic Temperature (-196°C)
Figure 50. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Temperature (2021-2032)
Figure 51. World Cell and Advanced Therapies Supply Chain Management Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 52. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2025
Figure 53. Biobank
Figure 54. Cell Therapy Lab
Figure 55. Hospital
Figure 56. Research Institute
Figure 57. Commercial Organization
Figure 58. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2021-2032)
Figure 59. Cell and Advanced Therapies Supply Chain Management Industrial Chain
Figure 60. Methodology
Figure 61. Research Process and Data Source
Figure 1. Cell and Advanced Therapies Supply Chain Management Picture
Figure 2. World Cell and Advanced Therapies Supply Chain Management Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Cell and Advanced Therapies Supply Chain Management Total Revenue (2021-2032) & (USD Million)
Figure 4. World Cell and Advanced Therapies Supply Chain Management Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Cell and Advanced Therapies Supply Chain Management Revenue (2021-2032) & (USD Million)
Figure 13. Cell and Advanced Therapies Supply Chain Management Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 16. World Cell and Advanced Therapies Supply Chain Management Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 18. China Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 23. India Cell and Advanced Therapies Supply Chain Management Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Cell and Advanced Therapies Supply Chain Management by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Advanced Therapies Supply Chain Management Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Advanced Therapies Supply Chain Management Markets in 2025
Figure 27. United States VS China: Cell and Advanced Therapies Supply Chain Management Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Cell and Advanced Therapies Supply Chain Management Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Cell and Advanced Therapies Supply Chain Management Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type in 2025
Figure 31. Cloud
Figure 32. On-premises
Figure 33. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Type (2021-2032)
Figure 34. World Cell and Advanced Therapies Supply Chain Management Market Size by Supply Chain, (USD Million), 2021 & 2025 & 2032
Figure 35. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Supply Chain in 2025
Figure 36. Collection
Figure 37. Production and Manufacturing
Figure 38. Cold Chain Transportation
Figure 39. Storage
Figure 40. Clinical Use
Figure 41. Others
Figure 42. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Supply Chain (2021-2032)
Figure 43. World Cell and Advanced Therapies Supply Chain Management Market Size by Temperature, (USD Million), 2021 & 2025 & 2032
Figure 44. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Temperature in 2025
Figure 45. Ambient Temperature (15-25°C)
Figure 46. Refrigerated (2-8°C)
Figure 47. Frozen (-20°C)
Figure 48. Deep-frozen (-80°C)
Figure 49. Cryogenic Temperature (-196°C)
Figure 50. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Temperature (2021-2032)
Figure 51. World Cell and Advanced Therapies Supply Chain Management Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 52. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application in 2025
Figure 53. Biobank
Figure 54. Cell Therapy Lab
Figure 55. Hospital
Figure 56. Research Institute
Figure 57. Commercial Organization
Figure 58. World Cell and Advanced Therapies Supply Chain Management Market Size Market Share by Application (2021-2032)
Figure 59. Cell and Advanced Therapies Supply Chain Management Industrial Chain
Figure 60. Methodology
Figure 61. Research Process and Data Source
